Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes

Virology

Volumn 433, Issue 2, 2012, Pages 367-376

  Li, Juan ^a   Murtaugh, Michael P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Animal health; Arterivirus; Envelope glycoprotein; GP5; Immunity; Neutralizing antibody; PRRSV; Swine

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 5; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; IMMUNIZATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SWINE; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; EPITOPES; FEMALE; IMMUNIZATION; MACROPHAGES, ALVEOLAR; MALE; MOLECULAR SEQUENCE DATA; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUS SCROFA; SWINE; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS;

ANIMALIA; ARTERIVIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

EID: 84867221795     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.026     Document Type: Article

References (70)

1. Allende R., Laegreid W.W., Kutish G.F., Galeota J.A., Wills R.W., Osorio F.A. Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J. Virol. 2000, 74(22):10834-10837.
2. Ansari I.H., Kwon B., Osorio F.A., Pattnaik A.K. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J. Virol. 2006, 80(8):3994-4004.
3. Baker R.B., Yu W., Fuentes M., Johnson C.R., Peterson L., Rossow K., Daniels C.S., Polson D., Murtaugh M.P. Prairie dog (Cynomys ludovicianus) is not a host for porcine reproductive and respiratory syndrome virus. J. Swine Health Prod. 2007, 15:22-29.
4. Balasuriya U.B., MacLachlan N.J. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 2004, 102(3):107-129.
5. Balasuriya U.B., Patton J.F., Rossitto P.V., Timoney P.J., McCollum W.H., MacLachlan N.J. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Virology 1997, 232(1):114-128.
6. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Osorio F.A. Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 2002, 21(1-2):21-29.
7. Batista L., Pijoan C., Dee S., Olin M., Molitor T., Joo H.S., Xiao Z., Murtaugh M. Virological and immunological responses to porcine reproductive and respiratory syndrome virus in a large population of gilts. Can. J. Vet. Res. 2004, 68(4):267-273.
8. Benfield D.A., Nelson E., Collins J.E., Harris L., Goyal S.M., Robison D., Christianson W.T., Morrison R.B., Gorcyca D., Chladek D. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J. Vet. Diagn. Invest. 1992, 4(2):127-133.
9. Calvert J.G., Slade D.E., Shields S.L., Jolie R., Mannan R.M., Ankenbauer R.G., Welch S.K. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. J. Virol. 2007, 81(14):7371-7379.
10. Cancel-Tirado S., Evans R., Yoon K. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet. Immunol. Immunopathol. 2004, 102(3):249-262.
11. L): induction of virus-neutralizing antibody and assessment of protection in ponies. J. Gen Virol. 2001, 82(Pt 10):2425-2435.
12. Chirnside E.D., de Vries A.A., Mumford J.A., Rottier P.J. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J. Gen. Virol. 1995, 76(Pt 8):1989-1998.
13. Collins J.E., Benfield D.A., Christianson W.T., Harris L., Hennings J.C., Shaw D.P., Goyal S.M., McCullough S., Morrison R.B., Joo H.S., Gorcyca D.E., Chladek D.W. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J. Vet. Diagn. Invest. 1992, 4(2):117-126.
14. Costers S., Vanhee M., Van Breedam W., Van Doorsselaere J., Geldhof M., Nauwynck H.J. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution. Virus Res. 2010, 154(1-2):104-113.
15. Das P.B., Dinh P.X., Ansari I.H., de Lima M., Osorio F.A., Pattnaik A.K. The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J. Virol. 2010, 84(4):1731-1740.
16. Das P.B., Vu H.L.X., Dinh P.X., Cooney J.L., Kwon B., Osorio F.A., Pattnaik A.K. Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response. Virology 2011, 410(2):385-394.
17. de Abin M.F., Spronk G., Wagner M., Fitzsimmons M., Abrahante J.E., Murtaugh M.P. Comparative infection efficiency of Porcine reproductive and respiratory syndrome virus field isolates on MA104 cells and porcine alveolar macrophages. Can. J. Vet. Res. 2009, 73(3):200-204.
18. Dea S., Gagnon C.A., Mardassi H., Pirzadeh B., Rogan D. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch. Virol. 2000, 145(4):659-688.
19. Delputte P.L., Vanderheijden N., Nauwynck H.J., Pensaert M.B. Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages. J. Virol. 2002, 76(9):4312-4320.
20. Dokland T. The structural biology of PRRSV. Virus Res. 2010, 154:86-97.
21. Indik S., Valicek L., Klein D., Klanova J. Variations in the major envelope glycoprotein GP5 of Czech strains of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2000, 81(Pt 10):2497-2502.
22. Jiang W., Jiang P., Li Y., Tang J., Wang X., Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet. Immunol. Immunopathol. 2006, 113(1-2):169-180.
23. Jiang W., Jiang P., Wang X., Li Y., Wang X., Du Y. Influence of porcine reproductive and respiratory syndrome virus GP5 glycoprotein N-linked glycans on immune responses in mice. Virus Genes 2007, 35(3):663-671.
24. Jiang Y., Fang L., Xiao S., Zhang H., Pan Y., Luo R., Li B., Chen H. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 2007, 25(3):547-560.
25. Jiang Y., Xiao S., Fang L., Yu X., Song Y., Niu C., Chen H. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 2006, 24(15):2869-2879.
26. Johnson C.R., Griggs T.F., Gnanandarajah J., Murtaugh M.P. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J. Gen. Virol. 2011, 92(Pt 5):1107-1116.
27. Johnson C.R., Yu W., Murtaugh M.P. Cross-reactive antibody responses to nsp1 and nsp2 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2007, 88(Pt 4):1184-1195.
28. Kim H.S., Kwang J., Yoon I.J., Joo H.S., Frey M.L. Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Arch. Virol. 1993, 133(3-4):477-483.
29. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 2004, 22(31-32):4183-4190.
30. Labarque G., Van Gucht S., Van Reeth K., Nauwynck H., Pensaert M. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet. Microbiol. 2003, 95(3):187-197.
31. Labarque G.G., Nauwynck H.J., Van Reeth K., Pensaert M.B. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. J. Gen. Virol. 2000, 81(Pt 5):1327-1334.
32. Li K., Chen Z., Plagemann P. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology 1998, 242(2):239-245.
33. Lin G., Pearson A.E., Scamurra R.W., Zhou Y., Baarsch M.J., Weiss D.J., Murtaugh M.P. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem. 1994, 269(1):77-85.
34. Loemba H.D., Mounir S., Mardassi H., Archambault D., Dea S. Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus. Arch. Virol. 1996, 141(3-4):751-761.
35. Lopez O.J., Oliveira M.F., Garcia E.A., Kwon B.J., Doster A., Osorio F.A. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin. Vaccine Immunol. 2007, 14(3):269-275.
36. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 2004, 102(3):155-163.
37. Mardassi H., Massie B., Dea S. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 1996, 221(1):98-112.
38. Mardassi H., Mounir S., Dea S. Molecular analysis of the ORFs 3 to 7 of porcine reproductive and respiratory syndrome virus, Quebec reference strain. Arch. Virol. 1995, 140(8):1405-1418.
39. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet. Microbiol. 2000, 74(4):309-329.
40. Molina R.M., Cha S.H., Chittick W., Lawson S., Murtaugh M.P., Nelson E.A., Christopher-Hennings J., Yoon K.J., Evans R., Rowland R.R., Zimmerman J.J. Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection. Vet. Immunol. Immunopathol. 2008, 126(3-4):283-292.
41. Murtaugh M.P., Genzow M. Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). Vaccine 2011, 29(46):8192-8204.
42. Murtaugh M.P., Stadejek T., Abrahante J.E., Lam T.T., Leung F.C. The ever-expanding diversity of porcine reproductive and respiratory syndrome virus. Virus Res 2010, 154(1-2):18-30.
43. Murtaugh M.P., Xiao Z., Zuckermann F. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol. 2002, 15(4):533-547.
44. Nelsen C.J., Murtaugh M.P., Faaberg K.S. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J. Virol. 1999, 73(1):270-280.
45. Nelson E.A., Christopher-Hennings J., Benfield D. Serum immune response to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J. Vet. Diagn. Invest. 1994, 6:410-415.
46. Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., Zuckermann F., Laegreid W.W. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 2002, 302(1):9-20.
47. Ostrowski M., Galeota J.A., Jar A.M., Platt K.B., Osorio F.A., Lopez O.J. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 2002, 76(9):4241-4250.
48. Pirzadeh B., Dea S. Monoclonal antibodies to the ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. J. Gen. Virol. 1997, 78:1867-1873.
49. Pirzadeh B., Dea S. Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 1998, 79:989-999.
50. Plagemann P.G. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Virology 2001, 290(1):11-20.
51. Plagemann P.G. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2004, 102(3):263-275.
52. Plagemann P.G., Rowland R.R., Faaberg K.S. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch. Virol. 2002, 147(12):2327-2347.
53. Shen G., Jin N., Ma M., Jin K., Zheng M., Zhuang T., Lu H., Zhu G., Jin H., Jin M., Huo X., Qin X., Yin R., Li C., Li H., Li Y., Han Z., Chen Y., Jin M. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 2007, 25(21):4193-4202.
54. Thanawongnuwech R., Suradhat S. Taming PRRSV: revisiting the control strategies and vaccine design. Virus Res. 2010, 154(1-2):133-140.
55. Van Breedam W., Van Gorp H., Zhang J.Q., Crocker P.R., Delputte P.L., Nauwynck H.J. The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. PLoS Pathogen 2010, 6(1):e1000730.
56. Van Gorp H., Van Breedam W., Delputte P.L., Nauwynck H.J. Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2008, 89(Pt 12):2943-2953.
57. Vanhee M., Van Breedam W., Costers S., Geldhof M., Noppe Y., Nauwynck H. Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies. Vaccine 2011, 29(29-30):4794-4804.
58. Vu H.L., Kwon B., Yoon K.J., Laegreid W.W., Pattnaik A.K., Osorio F.A. Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J. Virol. 2011, 85(11):5555-5564.
59. Wang L., Zhang H., Suo X., Zheng S., Feng W.H. Increase of CD163 but not sialoadhesin on cultured peripheral blood monocytes is coordinated with enhanced susceptibility to porcine reproductive and respiratory syndrome virus infection. Vet. Immunol. Immunopathol. 2011, 141(3-4):209-220.
60. Weiland E., Wieczorek-Krohmer M., Kohl D., Conzelmann K.K., Weiland F. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet. Microbiol. 1999, 66(3):171-186.
61. Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., Kragten C., van Buiten L., den Besten A., Wagenaar F., Broekhuijsen J.M., Moonen P.L.J.M., Zetstra T., de Boer E.A., Tibben H.J., de Jong M.F., van't Veld P., Groenland G.J.R., van Gennep J.A., Voets M.T., Verheijden J.H.M., Braamskamp J. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q 1991, 13(3):121-130.
62. Wills R.W., Zimmerman J.J., Yoon K.J., Swenson S.L., McGinley M.J., Hill H.T., Platt K.B., Christopher-Hennings J., Nelson E.A. Porcine reproductive and respiratory syndrome virus: a persistent infection. Vet. Microbiol. 1997, 55(1-4):231-240.
63. Wissink E.H., Kroese M.V., van Wijk H.A., Rijsewijk F.A., Meulenberg J.J., Rottier P.J. Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus. J. Virol. 2005, 79(19):12495-12506.
64. Wissink E.H., van Wijk H.A., Kroese M.V., Weiland E., Meulenberg J.J., Rottier P.J., van Rijn P.A. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. J. Gen. Virol. 2003, 84(Pt 6):1535-1543.
65. Wu W.H., Fang Y., Farwell R., Steffen-Bien M., Rowland R.R., Christopher-Hennings J., Nelson E.A. A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. Virology 2001, 287(1):183-191.
66. Yang L., Frey M.L., Yoon K.J., Zimmerman J.J., Platt K.B. Categorization of North American porcine reproductive and respiratory syndrome viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to neutralization. Arch. Virol. 2000, 145(8):1599-1619.
67. Yoon K.J., Wu L.L., Zimmerman J.J., Hill H.T., Platt K.B. Antibody-dependent enhancement (ADE) of porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs. Viral Immunol. 1996, 9(1):51-63.
68. Zhang Y., Sharma R.D., Paul P.S. Monoclonal antibodies against conformationally dependent epitopes on porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 1998, 63(2-4):125-136.
69. Zhou L., Yang H. Porcine reproductive and respiratory syndrome in China. Virus Res. 2010, 154:31-37.
70. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 2007, 123(1-3):69-85.